Artículo

La versión final de este artículo es de uso interno de la institución.
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Antithrombin (AT) high affinity of unfractionated heparin (UFH) resides in a specific pentasaccharide sequence. Heparin also regulates complement activity on the classical and the alternative pathways. Most experimental pieces of evidence accumulated show that these important activities reside in different segments of the heparin molecule. We demonstrated in previous papers that a low ionic strength and the presence of calcium ions are essential to detect specific interactions between glycosaminoglycans and proteins. Then these very strict conditions were used, and we demonstrated that the first protein complex of the human complement cascade recognizes in the UFH a fraction with very high anticoagulant activity. After isolation from the precipitate of the interaction, this fraction of heparin also contained the pentasaccharide sequence responsible for the great affinity with AT: in fact, it was strongly bound to a resin of AT agarose, and to detach it, an ionic strength of 0.6 M sodium chloride was required. In this way, the heparin regions responsible for the anticoagulant activity and also for the effects over the complement system were identified on the same short segment of the heparin molecule, which includes the active fraction of the glycosaminoglycan. The differences with early results could be explained by our experimental conditions of low ionic strength and the presence of calcium ions used for the interaction of the protein and the glycosaminoglycan. © 2002 Published by Elsevier Science Ltd.

Registro:

Documento: Artículo
Título:Antithrombin and first complement protein recognize the same active heparin fraction
Autor:Calabrese, G.C.; Recondo, E.F.; Fernandez De Recondo, M.E.
Filiación:Departamento de Ciencias Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 954/956, Buenos Aires 1110, Argentina
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Ciudad Universitaria, Pabellón II, 4 Piso, Nuez, Buenos Aires, 1428, Argentina
Palabras clave:Antithrombin; C1; Divalent cations; Heparin; Interactions; agarose; antithrombin; calcium ion; complement; glycosaminoglycan; heparin; pentasaccharide; resin; sodium chloride; anticoagulant agent; antithrombin III; calcium; complement component C1; heparin; anticoagulation; article; binding affinity; complement system; complex formation; ionic strength; priority journal; protein binding; affinity chromatography; binding site; human; isolation and purification; metabolism; osmolarity; precipitation; Anticoagulants; Antithrombin III; Binding Sites; Calcium; Chromatography, Affinity; Complement 1; Heparin; Human; Osmolar Concentration; Precipitation; Protein Binding; Support, Non-U.S. Gov't; Anticoagulants; Binding Sites; Calcium; Chromatography, Affinity; Complement C1; Humans; Osmolar Concentration; Precipitation; Protein Binding
Año:2002
Volumen:105
Número:6
Página de inicio:537
Página de fin:541
DOI: http://dx.doi.org/10.1016/S0049-3848(02)00062-2
Título revista:Thrombosis Research
Título revista abreviado:Thromb. Res.
ISSN:00493848
CODEN:THBRA
CAS:Anticoagulants; Antithrombin III, 9000-94-6; Calcium, 7440-70-2; Complement 1; Heparin, 9005-49-6; Complement C1
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00493848_v105_n6_p537_Calabrese

Referencias:

  • Almeda, S., Rosenberg, R.D., Bing, D.H., The binding properties of human complement component C1q: Interaction with mucopolysaccharides (1983) J Biol Chem, 258, pp. 785-791
  • Kazatchkine, M.D., Fearon, D.T., Metcalfe, D.D., Rosenberg, R.D., Austen, K.F., Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase (1981) J Clin Invest, 67, pp. 223-228
  • Maillet, F., Choay, J., Kazatchkine, M.D., Structure function relationships in the inhibitory effect of heparin on complement activation: Independency of the anticoagulant and anticomplementary sites on the heparin molecule (1988) Mol Immunol, 25 (9), pp. 917-923
  • Hennink, W.E., Klarx, J.P.A.M., Van Dijk, H., Feijen, J., Complement inhibitory and anticoagulant activities of fractionated heparins (1984) Thromb Res, 36, pp. 281-292
  • Fernández de Recondo, M.E., Legorburu, C., Monge, J.C., Recondo, E.F., Heparin and Concanavalin A interaction: Isolation of a fraction with higher anticoagulant activity (1988) Biochem Biophys Res Commun, 155 (1), pp. 216-223
  • Monge, J.C., Recondo, E.F., Fernández de Recondo, M.E., Heparin and Concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity (1989) Thromb Res, 54, pp. 237-243
  • Fernández de Recondo, M.E., Monge, J.C., Recondo, E.F., Interaction of Concanavalin A with a fraction of dermatan sulphate containing a very high anticoagulant activity (1995) Cell Mol Biol, 41 (4), pp. 465-472
  • Calabrese, G.C., Recondo, M.M., Fernández de Recondo, M.E., Recondo, E.F., The first component of the human complement system recognizes the active fraction of heparin (1997) Cell Mol Biol, 43 (2), pp. 237-242
  • Calabrese, G.C., Leocata Nieto, F., Recondo, E.F., Fernandez de Recondo, M.E., An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system (2001) Cell Mol Biol, 47 (16), pp. OL119-OL123
  • Bing, D., Purification of the first component of human complement by affinity chromatography on human gamma globulin linked to Sepharose (1971) J Immunol, 107 (5), pp. 1243-1249
  • Bing, D., Nature of active site of a subunit of the first component of human complement (1969) Biochemistry, 8 (11), pp. 4503-4509
  • Boneu, B., Low molecular weight heparin therapy: Is monitoring needed? (1994) Thromb Haemostasis, 72 (3), pp. 330-334
  • Liszewski, M., Atkinson, J., The complement system (1993) Fundamental immunology, pp. 917-939. , W.E. Paul. New York: Raven Press
  • Hemker, H.C., Beguin, S., Kakkar, V.V., Can the haemorrhagic component of heparin be identified? Or an attempt at clean thinking on a dirty drug (1996) Haemostasis, 26 (3), pp. 117-126
  • Doutremepuich, C., Azougagh Oualane, F., Doutremepuich, F., Fareed, J., New class of heparin derivates with a potent antithrombotic effect and a very limited hemorrhagic activity (1996) Thromb Res, 83 (3), pp. 217-228

Citas:

---------- APA ----------
Calabrese, G.C., Recondo, E.F. & Fernandez De Recondo, M.E. (2002) . Antithrombin and first complement protein recognize the same active heparin fraction. Thrombosis Research, 105(6), 537-541.
http://dx.doi.org/10.1016/S0049-3848(02)00062-2
---------- CHICAGO ----------
Calabrese, G.C., Recondo, E.F., Fernandez De Recondo, M.E. "Antithrombin and first complement protein recognize the same active heparin fraction" . Thrombosis Research 105, no. 6 (2002) : 537-541.
http://dx.doi.org/10.1016/S0049-3848(02)00062-2
---------- MLA ----------
Calabrese, G.C., Recondo, E.F., Fernandez De Recondo, M.E. "Antithrombin and first complement protein recognize the same active heparin fraction" . Thrombosis Research, vol. 105, no. 6, 2002, pp. 537-541.
http://dx.doi.org/10.1016/S0049-3848(02)00062-2
---------- VANCOUVER ----------
Calabrese, G.C., Recondo, E.F., Fernandez De Recondo, M.E. Antithrombin and first complement protein recognize the same active heparin fraction. Thromb. Res. 2002;105(6):537-541.
http://dx.doi.org/10.1016/S0049-3848(02)00062-2